Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   JOURNAL OF KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES (BEHBOOD)   Summer 2002 , Volume 6 , Number 2; Page(s) 44 To 47.
 
Paper: 

LONG-TERM SURVIVAL IN A PATIENT WITH CHRONIC MYELOGENOUS LEUKEMIA WITHOUT ANY TREATMENT

 
 
Author(s):  SHAHRIARI A., EMAAMI H.R.
 
* 
 
Abstract: 

Chronic myelogenous leukemia (CML) is a myeloproliferative disease with a well known course. With chemotherapy, average survival of these patients is 3-5 years. All of the long term survivors of CML have been treated patients. Here we are reporting on a long term survivor (more than 10 years) without treatment.

 
Keyword(s): CHRONIC MYELOGENOUS LEUKEMIA, SURVIVAL, CLINICAL COURSE
 
References: 
    exThe server principal "sidrdro" is not able to access the database "admin_Host353" under the current security context.
 
  Persian Abstract Yearly Visit 40
 
Latest on Blog
Enter SID Blog